Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$143.37−1.09 (-0.75%)
Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%
Merck pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Merck's pe ratio was 118.4× on Nov 10, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 11.2× to 942.5×, with a median of 20.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 118.4× | +104.5 |
| 2025 | Dec 31, 2025 | 13.9× | −7.0 |
| 2024 | Dec 31, 2024 | 20.9× | −39.7 |
| 2023 | Dec 29, 2023 | 60.6× | +42.1 |
| 2022 | Dec 30, 2022 | 18.5× | −8.5 |
| 2021 | Dec 31, 2021 | 27.0× | +8.9 |
| 2020 | Dec 31, 2020 | 18.1× | −7.3 |
| 2019 | Dec 31, 2019 | 25.4× | −35.7 |
| 2018 | Dec 31, 2018 | 61.1× | +7.0 |
| 2017 | Dec 29, 2017 | 54.1× | +24.1 |
| 2016 | Dec 30, 2016 | 30.0× | +15.9 |
| 2015 | Dec 31, 2015 | 14.1× | −24.5 |
| 2014 | Dec 31, 2014 | 38.6× | +14.5 |
| 2013 | Dec 31, 2013 | 24.2× | +5.5 |
| 2012 | Dec 31, 2012 | 18.7× | +6.8 |
| 2011 | Jan 31, 2011 | 11.9× | −1.0 |
| 2010 | Dec 31, 2010 | 13.0× | – |
See a number that looks wrong?